Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

NCT02206776 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped poor tolerability and low enrollment rate

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Intranasal Ketamine
DRUG: Intranasal Midazolam

Sponsor

New York State Psychiatric Institute